PRLD Insider Trading

Insider Ownership Percentage: 62.80%
Insider Buying (Last 12 Months): $115,750.00
Insider Selling (Last 12 Months): $0.00

Prelude Therapeutics Insider Trading History Chart

This chart shows the insider buying and selling history at Prelude Therapeutics by year and by quarter.

Skip ChartChart Data in Insider Trading History Table

Prelude Therapeutics Share Price & Price History

Current Price: $1.30
Price Change: Price Increase of +0.412 (46.40%)
As of 12/20/2024 06:40 PM ET

This chart shows the closing price history over time for PRLD up to the past year.

Skip Chart and Table DataPrice Data in Insider Trading History Table
Days: 30 | 90 | 365

Prelude Therapeutics Insider Trading History

Transaction DateInsider NameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionShares Held After TransactionDetails
12/19/2024Bryant David LimCFOBuy25,000$0.91$22,750.0027,400View SEC Filing Icon  
12/18/2024Krishna VaddiCEOBuy100,000$0.93$93,000.001,167,275View SEC Filing Icon  
5/24/2023Krishna VaddiCEOBuy1,000$5.01$5,010.001,066,375View SEC Filing Icon  
5/22/2023Orbimed Advisors LlcDirectorBuy869,565$5.75$4,999,998.7510,119,756View SEC Filing Icon  
4/6/2023Jane HuangCMOSell13,280$6.12$81,273.6024,220View SEC Filing Icon  
12/20/2022Krishna VaddiCEOBuy19,188$5.13$98,434.44120,665View SEC Filing Icon  
12/8/2022Laurent ChardonnetCFOBuy10,000$4.76$47,600.0035,873View SEC Filing Icon  
6/1/2022Laurent ChardonnetCFOBuy10,000$4.23$42,300.0024,500View SEC Filing Icon  
See Full Table

SEC Filings (Institutional Ownership Changes) for Prelude Therapeutics (NASDAQ:PRLD)

79.72% of Prelude Therapeutics stock is owned by institutions. Institutional ownership can be a sign of analyst confidence in the fundamentals of the stock.

Institutional Buying and Selling by Quarter

This chart shows the instiutional buying and selling at PRLD by year and by quarter.

Skip Institutional Buying and Selling Chart and Table DataRead Chart Data in Institutional Trading History Table

Prelude Therapeutics Institutional Trading History

Reporting DateHedge FundShares HeldMarket Value% of PortfolioQuarterly Change in SharesOwnership in CompanyDetails
11/19/2024Barclays PLC27,165$57K0.0%+86.0%0.049%Search for SEC Filing on Google Icon
11/16/2024Geode Capital Management LLC391,716$0.81M0.0%+8.2%0.712%Search for SEC Filing on Google Icon
11/15/2024Barclays PLC27,165$57K0.0%+86.0%0.049%Search for SEC Filing on Google Icon
11/15/2024XTX Topco Ltd48,239$100K0.0%N/A0.088%Search for SEC Filing on Google Icon
11/15/2024State Street Corp286,046$0.59M0.0%+35.1%0.520%Search for SEC Filing on Google Icon
11/15/2024Jacobs Levy Equity Management Inc.174,979$0.36M0.0%+885.2%0.318%Search for SEC Filing on Google Icon
11/14/2024Walleye Capital LLC83,175$0.17M0.0%+446.2%0.151%Search for SEC Filing on Google Icon
11/12/2024Massachusetts Financial Services Co. MA549,530$1.14M0.0%+5.2%0.999%Search for SEC Filing on Google Icon
10/10/2024Exchange Traded Concepts LLC64,409$0.13M0.0%+32.2%0.153%Search for SEC Filing on Google Icon
8/15/2024The Manufacturers Life Insurance Company70,045$0.27M0.0%-3.1%0.166%Search for SEC Filing on Google Icon
8/9/2024Renaissance Technologies LLC206,600$0.79M0.0%-15.6%0.491%Search for SEC Filing on Google Icon
8/9/2024Dimensional Fund Advisors LP29,074$0.11M0.0%+103.2%0.069%Search for SEC Filing on Google Icon
8/9/2024Massachusetts Financial Services Co. MA522,375$1.99M0.0%+2.8%1.241%Search for SEC Filing on Google Icon
7/26/2024Bank of New York Mellon Corp36,276$0.14M0.0%-9.5%0.086%Search for SEC Filing on Google Icon
5/16/2024Kennedy Capital Management LLC25,035$0.12M0.0%N/A0.059%Search for SEC Filing on Google Icon
5/15/2024Price T Rowe Associates Inc. MD941,971$4.47M0.0%-9.7%2.239%Search for SEC Filing on Google Icon
5/10/2024Acadian Asset Management LLC22,110$0.10M0.0%+42.7%0.053%Search for SEC Filing on Google Icon
5/10/2024Vanguard Group Inc.1,016,999$4.82M0.0%+1.0%2.417%Search for SEC Filing on Google Icon
2/15/2024Boxer Capital LLC2,568,287$10.97M0.5%+2.9%4.684%Search for SEC Filing on Google Icon
2/14/2024Pale Fire Capital SE63,581$0.27M0.0%+106.6%0.116%Search for SEC Filing on Google Icon
1/12/2024SG Americas Securities LLC13,100$56K0.0%N/A0.024%Search for SEC Filing on Google Icon
1/5/2024Exchange Traded Concepts LLC44,087$0.19M0.0%+34.0%0.080%Search for SEC Filing on Google Icon
11/14/2023Pale Fire Capital SE30,781$95K0.0%N/A0.056%Search for SEC Filing on Google Icon
11/13/2023FMR LLC5,131,433$15.86M0.0%-13.6%9.359%Search for SEC Filing on Google Icon
11/7/2023Barclays PLC13,316$42K0.0%+120.0%0.024%Search for SEC Filing on Google Icon
10/27/2023TD Asset Management Inc160,652$0.50M0.0%+100.0%0.293%Search for SEC Filing on Google Icon
10/18/2023Exchange Traded Concepts LLC32,907$0.10M0.0%+29.4%0.060%Search for SEC Filing on Google Icon
9/21/2023Barclays PLC6,052$27K0.0%-41.4%0.011%Search for SEC Filing on Google Icon
8/15/2023Boxer Capital LLC2,495,018$11.23M0.5%+256.9%4.552%Search for SEC Filing on Google Icon
8/9/2023TD Asset Management Inc80,326$0.36M0.0%+182.4%0.147%Search for SEC Filing on Google Icon
7/20/2023Exchange Traded Concepts LLC25,428$0.11M0.0%N/A0.053%Search for SEC Filing on Google Icon
5/16/2023Boxer Capital LLC699,047$3.99M0.2%N/A1.458%Search for SEC Filing on Google Icon
5/1/2023Virtu Financial LLC11,201$64K0.0%N/A0.023%Search for SEC Filing on Google Icon
2/14/2023683 Capital Management LLC28,631$0.17M0.0%N/A0.060%Search for SEC Filing on Google Icon
2/13/2023GSA Capital Partners LLP47,801$0.29M0.0%-11.8%0.100%Search for SEC Filing on Google Icon
2/10/2023New York Life Investment Management LLC82,000$0.50M0.0%+11.7%0.171%Search for SEC Filing on Google Icon
2/9/2023Citigroup Inc.60,072$0.36M0.0%+604.1%0.126%Search for SEC Filing on Google Icon
2/7/2023Bleakley Financial Group LLC22,325$0.14M0.0%N/A0.047%Search for SEC Filing on Google Icon
11/15/2022Caxton Associates LP85,992$0.57M0.1%+2.5%0.180%Search for SEC Filing on Google Icon
11/14/2022PDT Partners LLC12,641$84K0.0%-71.1%0.026%Search for SEC Filing on Google Icon
11/9/2022Massachusetts Financial Services Co. MA513,293$3.39M0.0%+7.3%1.073%Search for SEC Filing on Google Icon
10/25/2022Denali Advisors LLC8,200$54K0.0%N/A0.017%Search for SEC Filing on Google Icon
8/16/2022Corton Capital Inc.15,586$81K0.1%+42.8%0.033%Search for SEC Filing on Google Icon
8/16/2022Delphia USA Inc.16,940$88K0.1%N/A0.035%Search for SEC Filing on Google Icon
8/13/2022Massachusetts Financial Services Co. MA478,525$2.50M0.0%-0.7%1.000%Search for SEC Filing on Google Icon
8/12/2022Virtus ETF Advisers LLC24,005$0.13M0.0%+84.0%0.050%Search for SEC Filing on Google Icon
7/19/2022Commonwealth Equity Services LLC16,617$86K0.0%-18.8%0.035%Search for SEC Filing on Google Icon
5/11/2022Massachusetts Financial Services Co. MA482,119$3.33M0.0%+2.8%1.012%Search for SEC Filing on Google Icon
5/11/2022GSA Capital Partners LLP23,201$0.16M0.0%N/A0.049%Search for SEC Filing on Google Icon
5/6/2022IndexIQ Advisors LLC56,750$0.39M0.0%N/A0.119%Search for SEC Filing on Google Icon
5/5/2022New York State Common Retirement Fund4,992$34K0.0%-45.1%0.010%Search for SEC Filing on Google Icon
5/4/2022Commonwealth Equity Services LLC20,467$0.14M0.0%-10.4%0.043%Search for SEC Filing on Google Icon
3/3/2022Walleye Capital LLC41,954$0.52M0.0%N/A0.089%Search for SEC Filing on Google Icon
2/14/2022PDT Partners LLC35,907$0.45M0.0%N/A0.076%Search for SEC Filing on Google Icon
2/14/2022Virtus ETF Advisers LLC13,815$0.17M0.1%+119.6%0.029%Search for SEC Filing on Google Icon
2/14/2022Point72 Hong Kong Ltd3,872$48K0.0%+141.7%0.008%Search for SEC Filing on Google Icon
2/11/2022Ensign Peak Advisors Inc8,080$0.10M0.0%N/A0.017%Search for SEC Filing on Google Icon
2/11/2022Parkwood LLC12,667$0.16M0.0%N/A0.027%Search for SEC Filing on Google Icon
2/10/2022Qube Research & Technologies Ltd23,384$0.29M0.0%N/A0.050%Search for SEC Filing on Google Icon
2/10/2022Massachusetts Financial Services Co. MA468,797$5.84M0.0%-0.7%0.993%Search for SEC Filing on Google Icon
2/8/2022Swiss National Bank27,500$0.34M0.0%+34.1%0.058%Search for SEC Filing on Google Icon
2/1/2022Qube Research & Technologies Ltd23,384$0.29M0.0%N/A0.050%Search for SEC Filing on Google Icon
1/31/2022Commonwealth Equity Services LLC22,832$0.28M0.0%+69.4%0.048%Search for SEC Filing on Google Icon
12/14/2021UBS Asset Management Americas Inc.1,483,319$46.35M0.0%+15.2%3.142%Search for SEC Filing on Google Icon
11/15/2021Point72 Hong Kong Ltd1,602$50K0.0%N/A0.003%Search for SEC Filing on Google Icon
11/15/2021Cubist Systematic Strategies LLC21,755$0.68M0.0%+26.5%0.046%Search for SEC Filing on Google Icon
11/15/2021California State Teachers Retirement System13,524$0.42M0.0%-9.5%0.029%Search for SEC Filing on Google Icon
11/15/2021Rock Springs Capital Management LP362,359$11.32M0.2%-5.2%0.769%Search for SEC Filing on Google Icon
11/15/2021Morgan Stanley756,787$23.65M0.0%+472.6%1.607%Search for SEC Filing on Google Icon
11/12/2021Credit Suisse AG6,950$0.22M0.0%N/A0.015%Search for SEC Filing on Google Icon
11/12/2021Geode Capital Management LLC249,172$7.79M0.0%+11.6%0.529%Search for SEC Filing on Google Icon
11/10/2021Goldman Sachs Group Inc.8,659$0.27M0.0%-53.5%0.018%Search for SEC Filing on Google Icon
11/10/2021Citigroup Inc.24,268$0.76M0.0%-67.9%0.052%Search for SEC Filing on Google Icon
11/10/2021Rafferty Asset Management LLC36,936$1.15M0.0%-25.8%0.078%Search for SEC Filing on Google Icon
11/10/2021Alliancebernstein L.P.13,700$0.43M0.0%-23.5%0.029%Search for SEC Filing on Google Icon
11/10/2021Massachusetts Financial Services Co. MA472,246$14.76M0.0%+25.9%1.003%Search for SEC Filing on Google Icon
11/9/2021BlackRock Inc.725,962$22.69M0.0%+3.3%1.542%Search for SEC Filing on Google Icon
11/4/2021Deutsche Bank AG6,537$0.21M0.0%-82.4%0.014%Search for SEC Filing on Google Icon
11/1/2021SG Americas Securities LLC8,691$0.27M0.0%N/A0.018%Search for SEC Filing on Google Icon
10/29/2021Commonwealth Equity Services LLC13,482$0.42M0.0%+23.4%0.029%Search for SEC Filing on Google Icon
8/17/2021Logos Global Management LP400,000$11.45M1.0%N/A0.852%Search for SEC Filing on Google Icon
8/17/2021Metropolitan Life Insurance Co NY3,194$91K0.0%+106,366.7%0.007%Search for SEC Filing on Google Icon
8/17/2021Price T Rowe Associates Inc. MD400,802$11.48M0.0%-5.2%0.854%Search for SEC Filing on Google Icon
8/16/2021UBS Asset Management Americas Inc.1,287,735$36.87M0.0%+100.3%2.742%Search for SEC Filing on Google Icon
8/16/2021Cubist Systematic Strategies LLC17,197$0.49M0.0%+168.9%0.037%Search for SEC Filing on Google Icon
8/16/2021Hhlr Advisors LTD.583,333$16.70M0.2%-6.9%1.242%Search for SEC Filing on Google Icon
8/16/2021Morgan Stanley132,165$3.78M0.0%+449.0%0.281%Search for SEC Filing on Google Icon
8/16/2021Charles Schwab Investment Management Inc.72,623$2.08M0.0%-2.7%0.155%Search for SEC Filing on Google Icon
8/16/2021State Street Corp1,052,216$30.13M0.0%+20.5%2.241%Search for SEC Filing on Google Icon
8/16/2021Goldman Sachs Group Inc.18,617$0.53M0.0%-57.2%0.040%Search for SEC Filing on Google Icon
8/13/2021Northern Trust Corp118,677$3.40M0.0%+2.8%0.253%Search for SEC Filing on Google Icon
8/13/2021Jump Financial LLC13,700$0.39M0.0%+117.5%0.029%Search for SEC Filing on Google Icon
8/13/2021Geode Capital Management LLC223,252$6.39M0.0%+12.1%0.475%Search for SEC Filing on Google Icon
8/13/2021Vanguard Group Inc.1,126,047$32.24M0.0%+29.8%2.398%Search for SEC Filing on Google Icon
8/13/2021Massachusetts Financial Services Co. MA375,166$10.74M0.0%+33.4%0.799%Search for SEC Filing on Google Icon
8/13/2021FMR LLC6,552,499$187.60M0.0%+4.8%13.954%Search for SEC Filing on Google Icon
8/12/2021JPMorgan Chase & Co.6,889$0.20M0.0%+9.4%0.015%Search for SEC Filing on Google Icon
8/11/2021Commonwealth Equity Services LLC10,927$0.31M0.0%N/A0.023%Search for SEC Filing on Google Icon
8/11/2021Bank of New York Mellon Corp30,254$0.87M0.0%-2.5%0.064%Search for SEC Filing on Google Icon
8/11/2021BlackRock Inc.702,842$20.12M0.0%+3.1%1.497%Search for SEC Filing on Google Icon
Data available starting January 2016

See Full Table
Prelude Therapeutics logo
Prelude Therapeutics Incorporated, a clinical-stage biopharmaceutical company, focuses on the discovery and development of novel precision cancer medicines to underserved patients. It is developing PRT1419, a myeloid cell leukemia-1 inhibitor, which is in Phase 1 clinical trial for the treatment of selected relapsed/refractory myeloid or B-cell malignancies; PRT2527, a cyclin-dependent kinase, which is in Phase 1 clinical trial for the treatment of advanced solid tumors; PRT3645, a cyclin-dependent kinase 4/6 inhibitor, which is in Phase 1 clinical trial for the treatment of advanced and metastatic solid tumors; and PRT3879, a SMARCA2 selective protein degrader, which is in Phase 2/3 clinical trial for the treatment of advanced and metastatic solid tumors with loss of SMARCA4 due to truncating mutation and/or deletion. The company's CDK9 program is a regulator of cancer-promoting transcriptional programs, including MCL1, MYC and MYB. Prelude Therapeutics Incorporated was incorporated in 2016 and is based in Wilmington, Delaware.
Read More on Prelude Therapeutics

Today's Range

Now: $1.30
Low: $0.94
High: $1.45

50 Day Range

MA: $1.21
Low: $0.80
High: $1.94

52 Week Range

Now: $1.30
Low: $0.80
High: $6.80

Volume

4,433,679 shs

Average Volume

205,806 shs

Market Capitalization

$71.55 million

P/E Ratio

N/A

Dividend Yield

N/A

Beta

1.49

Who are the company insiders with the largest holdings of Prelude Therapeutics?

Prelude Therapeutics' top insider shareholders include:
  1. Orbimed Advisors Llc (Director)
  2. Krishna Vaddi (CEO)
  3. Bryant David Lim (CFO)
  4. Jane Huang (CMO)
Learn More about top insider investors at Prelude Therapeutics.

Who are the major institutional investors of Prelude Therapeutics?

Prelude Therapeutics' top institutional investors include:
  1. Massachusetts Financial Services Co. MA — 1.00%
  2. Geode Capital Management LLC — 0.71%
  3. State Street Corp — 0.52%
  4. Jacobs Levy Equity Management Inc. — 0.32%
  5. Walleye Capital LLC — 0.15%
  6. Exchange Traded Concepts LLC — 0.15%
Learn More about top institutional investors of Prelude Therapeutics stock.

Which major investors are buying Prelude Therapeutics stock?

Within the last quarter, PRLD stock was bought by institutional investors including:
  1. Jacobs Levy Equity Management Inc.
  2. State Street Corp
  3. Walleye Capital LLC
  4. XTX Topco Ltd
  5. Geode Capital Management LLC
  6. Massachusetts Financial Services Co. MA
  7. Exchange Traded Concepts LLC
  8. Barclays PLC
In the last year, these company insiders have bought Prelude Therapeutics stock:
  1. Orbimed Advisors Llc (Director)
  2. Krishna Vaddi (CEO)
  3. Bryant David Lim (CFO)
Learn More investors buying Prelude Therapeutics stock.